HEMITARTARATO DE RIVASTIGMINA 1,5 MG CAP DURA CT BL AL PLAS TRANS X 30

Apresentação · Câmara de Regulação do Mercado de Medicamentos (CMED), Secretaria Executiva exercida pela Agência Nacional de Vigilância Sanitária (ANVISA) · Brasil

  • Número de registro 1235202590136
  • GGREM 529920110069607
  • Código de barras 7897076922632

O que a fonte publica

Detentor do registro
RANBAXY FARMACÊUTICA LTDA
Princípios ativos
HEMITARTARATO DE RIVASTIGMINA
Embalagem
1,5 MG CAP DURA CT BL AL PLAS TRANS X 30
Regime de dispensação
Tarja Vermelha sob restrição
Tipo de produto
Genérico
Classe terapêutica
N7D1 - PRODUTOS ANTIALZHEIMER, INIBIDORES DA COLINESTERASE
Prescrição
Sob prescrição ou restrito

Nomes pelos quais este registro é encontrado

Dados completos da fonte
br:cmed:presentations:529920110069607
{
  "name": "HEMITARTARATO DE RIVASTIGMINA 1,5 MG CAP DURA CT BL AL PLAS TRANS X 30",
  "holder": "RANBAXY FARMACÊUTICA LTDA",
  "stripe": "Tarja Vermelha sob restrição",
  "barcodes": [
    "7897076922632"
  ],
  "confaz87": true,
  "currency": "BRL",
  "marketed": null,
  "ggremCode": "529920110069607",
  "useDomain": "unknown",
  "capApplies": null,
  "icmsExempt": false,
  "holderTaxId": "73.663.650/0001-90",
  "priceRegime": "Regulado",
  "productName": "HEMITARTARATO DE RIVASTIGMINA",
  "productType": "Genérico",
  "hospitalOnly": false,
  "presentation": "1,5 MG CAP DURA CT BL AL PLAS TRANS X 30",
  "sourceStatus": null,
  "supplyRegime": "Tarja Vermelha sob restrição",
  "factoryPrices": {
    "icms-0": "143.30",
    "icms-12": "162.84",
    "icms-17": "172.65",
    "icms-18": "174.76",
    "icms-19": "176.91",
    "icms-20": "179.13",
    "icms-21": "181.39",
    "icms-22": "183.72",
    "icms-23": "186.10",
    "icms-17.5": "173.70",
    "icms-19.5": "178.01",
    "icms-20.5": "180.25",
    "icms-22.5": "184.90",
    "icms-12-alc": "160.89",
    "icms-17-alc": "170.58",
    "icms-18-alc": "172.66",
    "icms-19-alc": "174.79",
    "icms-20-alc": "176.98",
    "icms-21-alc": "179.22",
    "icms-22-alc": "181.51",
    "icms-23-alc": "183.87",
    "withoutTaxes": "141.58",
    "icms-17.5-alc": "171.61",
    "icms-19.5-alc": "175.88",
    "icms-20.5-alc": "178.09",
    "icms-22.5-alc": "182.68"
  },
  "pisCofinsList": "Positiva",
  "substanceText": "HEMITARTARATO DE RIVASTIGMINA",
  "targetSpecies": [],
  "consumerPrices": {
    "icms-0": "197.52",
    "icms-12": "224.46",
    "icms-17": "237.98",
    "icms-18": "240.89",
    "icms-19": "243.85",
    "icms-20": "246.91",
    "icms-21": "250.03",
    "icms-22": "253.24",
    "icms-23": "256.52",
    "icms-17.5": "239.43",
    "icms-19.5": "245.37",
    "icms-20.5": "248.46",
    "icms-22.5": "254.87",
    "icms-12-alc": "222.42",
    "icms-17-alc": "235.82",
    "icms-18-alc": "238.69",
    "icms-19-alc": "241.64",
    "icms-20-alc": "244.66",
    "icms-21-alc": "247.76",
    "icms-22-alc": "250.93",
    "icms-23-alc": "254.19",
    "withoutTaxes": "195.73",
    "icms-17.5-alc": "237.24",
    "icms-19.5-alc": "243.14",
    "icms-20.5-alc": "246.20",
    "icms-22.5-alc": "252.54"
  },
  "invalidBarcodes": [],
  "activeSubstances": [
    "HEMITARTARATO DE RIVASTIGMINA"
  ],
  "therapeuticClass": "N7D1 - PRODUTOS ANTIALZHEIMER, INIBIDORES DA COLINESTERASE",
  "commercialisation": {
    "year": 2025,
    "marketed": true
  },
  "priceAnalysisNote": null,
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "br.anvisa.cmed-prices"
  },
  "patientEligibility": "not-assessed",
  "registrationNumber": "1235202590136",
  "targetSpeciesStatus": "not-reported",
  "administrativeStatus": "unknown",
  "prescriptionCategory": "prescription-or-restricted",
  "prescriptionRequired": true,
  "therapeuticClassCode": "N7D1",
  "commercialDestination": null,
  "registrationNumberFlag": null
}

Leia este registro a partir do seu próprio software

O mesmo registro, com todos os campos e sua procedência, está a uma requisição de distância. A chave de API é gratuita e funciona imediatamente.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=br" \
  --data-urlencode "sourceId=br.anvisa.cmed-prices" \
  --data-urlencode "id=br:cmed:presentations:529920110069607"